logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fernando Sabino Marques Monteiro

latin american cooperative oncology group
H指数:16
被引数:1,171

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sex-based differences in clinical outcomes of enfortumab vedotin and NECTIN-4 expression in urothelial cancer

基于性别的恩夫妥木单抗临床结局差异及尿路上皮癌中NECTIN-4表达

Nature Communications
IF15.7
2026-10-270
OAAI
Tarek Taha; Ayelet Alpert; Jalal Baranseh; Alessandro Rizzo; Francesco Ciccimarra; Enrique Grande; Joaquim Bellmunt; Sebastiano Buti; Francesco Massari; Shilpa Gupta; Fernando Sabino Marques Monteiro; Ravindran Kanesvaran; Giandomenico Roviello; Cristian Lolli; Yüksel Ürün; Hideki Takeshita; Avivit Peer; Aristotelis Bamias; Matteo Santoni; Ithai Waldhorn
Nutritional status and survival outcomes in patients with cancer treated with immune checkpoint inhibitors: The ARON-MOUSEION-20 systematic review and meta-analysis

免疫检查点抑制剂治疗癌症患者的营养状况与生存结局：ARON-MOUSEION-20系统评价与Meta分析

Clinical Nutrition ESPEN
IF2.6
2026-09-300
PRE
Chiara Paciolla; Elsa Vitale; Lorenza Maistrello; Antonella Daniele; Francesco Ciccimarra; Gerardo Cazzato; Mario Della Mura; Oronzo Brunetti; Tiziana Loconte; Fernando Sabino Marques Monteiro; Anna Albano; Patrizia Nardulli; Francesco Massari; Matteo Santoni; Alessandro Rizzo
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations

奥拉帕利在全球真实世界中对具有同源重组修复改变的转移性去势抵抗性前列腺癌患者的疗效

International Journal of Cancer
IF4.7
2026-08-310
OAAI
Lorena Incorvaia; Daniele Santini; Marc R. Matrana; Marco Maruzzo; Ray Manneh Kopp; Lorenzo Antonuzzo; Sergio Bracarda; Deniz Tural; Giuseppe Procopio; Maria T. Bourlon; Orazio Caffo; Martin Ignacio Zapata Laguado; Massimo Di Maio; Brigida Anna Maiorano; Vincenza Conteduca; Sabrina Rossetti; Helga Lipari; Thomas Büttner; Mimma Rizzo; Yüksel Ürün; Carlo Messina; Fernando Sabino Marques Monteiro; Andrey Soares; Mattia Puglisi; Alice Principi; Eleonora Lai; Giulia Mammone; Marco Stellato; Ilaria Depetris; Tancredi Didier Bazan Russo; Isadora Yasbick Spricido; Camila Bobato Lara Gismondi; Francesco Massari; Nicola Pavan; Matteo Santoni; Tarek Taha
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis

接受免疫检查点抑制剂治疗的癌症患者中的肌炎：ARON-MOUSEION-017系统评价与荟萃分析

Expert Opinion on Drug Safety
IF3.1
2026-08-140
PRE
Elsa Vitale; Gerardo Cazzato; Lorenza Maistrello; Mario Della Mura; Mauro Francesco Pio Maiorano; Francesco Ciccimarra; Oronzo Brunetti; Concetta Calabrò; Brigida Anna Maiorano; Fernando Sabino Marques Monteiro; Enes Erul; Francesco Massari; Alessandro Rizzo; Matteo Santoni
Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study)

基线疾病特征和铂类药物敏感性作为顺铂为基础化疗、阿维鲁姆单抗维持治疗和恩沃利单抗维多汀序贯疗法在晚期尿路上皮癌中的预后预测因素（ARON-2EV研究）

Targeted Oncology
IF4
2026-07-290
PRE
Mimma Rizzo; Sebastiano Buti; Ondřej Fiala; Lorena Incorvaia; Javier Molina-Cerrillo; Maria T. Bourlon; Wataru Fukuokaya; Fumihiko Urabe; Se Hoon Park; Karl Mayrhofer; Renate Pichler; Dora Niedersuess-Beke; Tarek Taha; Thomas Büttner; Aristotelis Bamias; Emmanuel Seront; Daniele Santini; Luciano Stumbo; Alejo Rodriguez-Vida; Francesco Massari; Fernando Sabino Marques Monteiro; Andrey Soares; Enrique Grande; Matteo Santoni
Real-world incidence of G3-G4 adverse events with enfortumab vedotin in patients with advanced urothelial carcinoma (ARON-2EV study)
Scientific Reports
IF3.9
2026-07-290
OA
Patrizia Giannatempo; Shilpa Gupta; Mimma Rizzo; Karl Mayrhofer; Renate Pichler; Dora Niedersuess-Beke; Ondrej Fiala; Javier Molina-Cerrillo; Marc R. Matrana; Randi Kinhel; Luca Galli; Alessia Salfi; Tomas Buchler; Alina Pirshtuk; Jawaher Ansari; Anca Zgura; Ray Manneh Kopp; Giandomenico Roviello; Jindrich Kopecky; Kirstin Binz; Akihiro Yano; Martin Angel; Se Hoon Park; Ravindran Kanesvaran; Zin W. Myint; Yüksel Ürün; Francesco Massari; Fernando Sabino Marques Monteiro; Kannan Sridharan; Matteo Santoni
Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV)

avelumab、pembrolizumab和enfortumab vedotin在具有鳞状分化的晚期尿路上皮癌患者中的真实世界有效性（ARON-2EV）

Cancer Immunology Immunotherapy
IF5.1
2026-03-240
OA
Mollica, Veronica; Massari, Francesco; Fujita, Kazutoshi; Giannatempo, Patrizia; Grande, Enrique; Buttner, Thomas; Bourlon, Maria T.; Taha, Tarek; Fukuokaya, Wataru; Myint, Zin W.; Pichler, Renate; Binz, Kirstin; Molina-cerrillo, Javier; Kopecky, Jindrich; De Liano, Alfonso Gomez; Kucharz, Jakub; Fiala, Ondrej; Matrana, Marc R.; Kopp, Ray Manneh; Di Civita, Mattia Alberto; Zgura, Anca; Ansari, Jawaher; Kihnel, Randi; De Felice, Francesca; Angel, Martin; Monteiro, Fernando Sabino M.; Soares, Andrey; Urun, Yuksel; Buti, Sebastiano; Santini, Daniele; Santoni, Matteo
Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis

癌症患者接受免疫检查点抑制剂治疗时的低钠血症：ARON-MOUSEION-014荟萃分析

Cancer and Metastasis Reviews
IF8.7
2026-03-170
PRE
Elsa Vitale; Lorenza Maistrello; Francesco Ciccimarra; Alessandro Rizzo; Andrey Soares; Oronzo Brunetti; Veronica Mollica; Brigida Anna Maiorano; Mauro Francesco Pio Maiorano; Fernando Sabino Marques Monteiro; Francesco Massari; Matteo Santoni
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group

Belzutifan单药治疗和联合疗法在肾细胞癌中的应用：ARON工作组从临床试验角度的视角

Expert Opinion on Pharmacotherapy
IF2.7
2026-02-011
PRE
Calabro, Concetta; Ciccimarra, Francesco; Rizzo, Alessandro; Cazzato, Gerardo; Della Mura, Mario; Taha, Tarek; Bourlon, Maria T.; Melichar, Bohuslav; Studentova, Hana; Schieber, Timothy J.; Nardulli, Patrizia; Molina-Cerrillo, Javier; Monteiro, Fernando Sabino Marques; Soares, Andrey; Massafra, Raffaella; Mollica, Veronica; Massari, Francesco; Kucharz, Jakub; Santoni, Matteo
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project

接受恩沃利单抗维多汀治疗的局部晚期或转移性尿路上皮癌患者的骨转移：ARON-2EV项目真实世界研究

Clinical and Experimental Medicine
IF3.5
2025-12-290
OAAI
Alessandro Rizzo; Zin W. Myint; Francesco Ciccimarra; Anca Zgura; Marc R. Matrana; Thomas Büttner; Jindrich Kopecky; Alejo Rodriguez Vida; Mimma Rizzo; Kazutoshi Fujita; Oronzo Brunetti; Daniele Santini; Se Hoon Park; Luigi Formisano; Alexandr Poprach; Jakub Kucharz; Maria Colomba Comes; Samantha Bove; Annarita Fanizzi; Raffaella Massafra; Gerardo Cazzato; Fernando Sabino Marques Monteiro; Veronica Mollica; Francesco Massari; Javier Molina Cerrillo; Matteo Santoni
Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis

免疫检查点抑制剂治疗癌症患者中的输注相关反应：ARON-MOUSEION-013系统评价与荟萃分析

Drug Design; Development and Therapy
IF0
2025-12-130
OA
Elsa Vitale; Alessandro Rizzo; Lorenza Maistrello; Omar Cauli; Oronzo Brunetti; Fernando Sabino Marques Monteiro; Andrey Soares; Matteo Santoni; Veronica Mollica; Francesco Massari
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study

转移时间作为转移性尿路上皮癌的预后因素：ARON-2研究的结果

Clinical & Experimental Metastasis
IF3.2
2025-11-210
PRE
Renate Pichler; Gerald Klinglmair; Kirstin Binz; Enrique Grande; Alina Pirshtuk; Hideki Takeshita; Yüksel Ürün; Javier Molina-Cerrillo; Zin W. Myint; Alfonso Gómez de Liaño; Augusto Mota; Alessia Salfi; Wataru Fukuokaya; Enrico Sammarco; Martin Angel; Jakub Kucharz; Deniz Tural; Ondřej Fiala; Alejo Rodriguez-Vida; Franco Morelli; Alexandr Poprach; Mobin Safi; Alvaro Pinto; Francesco Massari; Sebastiano Buti; Shilpa Gupta; Fernando Sabino Marques Monteiro; Andrey Soares; Nicola Battelli; Ravindran Kanesvaran; Matteo Santoni
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study

肾细胞癌辅助性帕博利珠单抗的实证据：多中心真实世界ARON-1研究的结果

Cancer Immunology, Immunotherapy
IF0
2025-11-140
OAAI
Ray Manneh Kopp; Francesco Massari; Enrique Grande; Timothy J. Schieber; Yüksel Ürün; Jindřich Kopecký; Javier Molina-Cerrillo; Umberto Basso; Jakub Kucharz; Thomas Büttner; Renate Pichler; Ondrej Fiala; Zin W. Myint; Luca Galli; Tomas Buchler; Mimma Rizzo; Hatice Bolek; Maria T. Bourlon; Vincenza Conteduca; Alvaro Pinto; Alessandro Rizzo; Matteo Rosellini; Giandomenico Roviello; Anca Zgura; Veronica Mollica; Antonia Partl; Ahmet Yildirim; Umut Akova; Sebastiano Buti; Fernando Sabino Marques Monteiro; Andrey Soares; Camillo Porta; Mehmet Asim Bilen; Haoran Li; Matteo Santoni
Re: Fernando Cotait Maluf, Karine Trindade, Daniel Preto, et al. Pembrolizumab plus Platinum-based Chemotherapy for Patients with Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.3266

Re: Fernando Cotait Maluf, Karine Trindade, Daniel Preto, et al. 帕姆布罗珠单抗联合铂类化疗用于晚期阴茎癌患者的治疗：非随机HERCULES（LACOG 0218）临床研究。JAMA Oncol. 即将发表。https://doi.org/10.1001/jamaoncol.2025.3266

European Urology
IF25.2
2025-11-140
PRE
Fernando Sabino Marques Monteiro; Matteo Santoni; Philippe E. Spiess
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)

与毒性相关的免疫治疗停药及结局：接受基于免疫联合治疗方案的晚期肾细胞癌患者（ARON-1研究）

International Journal of Cancer
IF4.7
2025-11-040
PRE
Javier Molina-Cerrillo; Giandomenico Roviello; Maria T. Bourlon; Hana Studentova; Ondrej Fiala; Linda Cerbone; Jakub Kucharz; Jawaher Ansari; Annalisa Zeppellini; Tarek Taha; Sebastiano Buti; Yüksel Ürün; Sarah Scagliarini; Haoran Li; Kaisa Sunela; Se Hoon Park; Mimma Rizzo; Anca Zgura; Rita Chiari; Emmanuel Seront; Martina Catalano; Marwan Ghosn; Alessandra Filosa; Andrey Soares; Francesco Massari; Fernando Sabino Marques Monteiro; Enrique Grande; Camillo Porta; Sergio Bracarda; Matteo Santoni
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort

在铂类化疗和帕博利珠单抗治疗后的转移性尿路上皮癌中恩沃利单抗维得尼单抗的疗效：ARON-2EV队列的多中心真实世界分析

European Urology Open Science
IF4.5
2025-11-030
OAAI
Ondrej Fiala; Francesco Grillone; Kazutoshi Fujita; Enrique Grande; Patrizia Giannatempo; Tarek Taha; Zin W. Myint; Thomas Büttner; Alfonso Gómez de Liaño; Ravindran Kanesvaran; Gaetano Facchini; Akihiro Yano; Luigi Formisano; Alexandr Poprach; Vincenza Conteduca; Alina Pirshtuk; Hana Studentova; Jindrich Kopecky; Enrico Sammarco; Augusto Mota; Lorena Incorvaia; Cecilia Nasso; Michele Maffezzoli; Aruni Ghose; Andrey Soares; Sebastiano Buti; Fernando Sabino Marques Monteiro; Francesco Massari; Shilpa Gupta; Joaquim Bellmunt; Giuseppe Luigi Banna; Matteo Santoni

研究方向

暂未获取到该数据
F
Francesco Massari
H 指数:65论文数:869被引数:1.8万
M
Matteo Santoni
H 指数:64论文数:636被引数:1.4万
S
Sebastiano Buti
H 指数:44论文数:657被引数:7,618
O
Ondřej Fiala
H 指数:23论文数:311被引数:1,930
A
Andrey Soares
H 指数:15论文数:108被引数:880
J
Javier Molina‐Cerrillo
H 指数:23论文数:153被引数:1,811
V
Veronica Mollica
H 指数:37论文数:291被引数:5,254
E
Enrique Grande
H 指数:48论文数:472被引数:1.3万
G
Giandomenico Roviello
H 指数:43论文数:447被引数:7,946
Z
Zin Myint
H 指数:17论文数:155被引数:1,348